FDA Grants Clearance to Medtronic’s Resolute Onyx Drug-Eluting Stent

May 2, 2017

Dublin–based Medtronic has received FDA approval for its Resolute Onyx drug-eluting stent (DES).

The device is designed with the transradial approach (through the wrist) including 5 Fr catheter compatibility with stent sizes up to 5.0 mm. The Resolute Onyx DES helps expand treatment options for patients with extra-large vessels.

The device uses the BioLinx polymer, a hydrophilic and hydrophobic blend, allowing rapid endothelial healing with minimal inflammation and low risk of stent thrombosis.

Sizes 4.5 mm and 5.0 mm DES are available in the U.S. — Cynthia Jessup

View today's stories